PAHC - Latest News

Phibro Animal Health Corporation (PAHC), operates in Healthcare / Drug Manufacturers - Specialty & Generic, trades on NASDAQ.

Market capitalization stands near $1.28B. Trailing twelve-month P/E ratio is 13.49. Beta to the broader market is 0.46.

The article list below shows the most recent PAHC headlines from major financial news vendors. For options traders, the most actionable items are earnings releases, analyst rating changes, M&A activity, and regulatory filings - each can drive a meaningful repricing of implied volatility and shift dealer hedging flow. Pair the news context with the implied-volatility skew and gamma exposure views to see whether the options market has already priced in the headline.

Recent PAHC Headlines

Wall Street Analysts Predict a 36.23% Upside in Phibro (PAHC): Here's What You Should Know

zacks.com - Jun 29, 2026

The average of price targets set by Wall Street analysts indicates a potential upside of 36. 2% in Phibro (PAHC).

PAHC vs. SYK: Which Stock Is the Better Value Option?

zacks.com - Jun 22, 2026

Investors interested in stocks from the Medical - Products sector have probably already heard of Phibro Animal Health (PAHC) and Stryker (SYK). But w

What Makes Phibro (PAHC) a New Buy Stock

zacks.com - Jun 17, 2026

Phibro (PAHC) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

Is Beaten-Down Phibro Animal Health Stock a Buy Following an Insider Purchase of 10,000 Shares?

fool.com - Jun 13, 2026

This animal health provider, serving global livestock markets, reported a notable insider buy in its latest SEC filing.

PAHC vs. SYK: Which Stock Should Value Investors Buy Now?

zacks.com - Jun 3, 2026

Investors looking for stocks in the Medical - Products sector might want to consider either Phibro Animal Health (PAHC) or Stryker (SYK). But which o

How News Affects PAHC Options Pricing

Headlines and scheduled events drive implied volatility in two distinct ways. Pre-event, IV typically inflates as uncertainty about the outcome rises; this is the implied-volatility expansion that creates the long-vol setup. Post-event, IV typically contracts sharply as uncertainty resolves; this is IV crush, which makes premium-selling structures profitable when they survive the underlying move. The size of the crush depends on how stretched pre-event IV is relative to the realized move. Track PAHC's implied vs realized volatility over the news cycle to size pre-event vs post-event positioning. For ticker-level dealer positioning context, the gamma exposure view shows whether dealers are positioned to amplify or dampen post-news moves.

Frequently asked PAHC news questions

What is the latest PAHC news headline?

The most recent PAHC headline (Jun 29, 2026) is "Wall Street Analysts Predict a 36.23% Upside in Phibro (PAHC): Here's What You Should Know". The five most recent stories with summaries and publication times are listed above, sourced from major financial news vendors.

How fresh is the PAHC news on this page?

News rows refresh roughly every 30 minutes during the trading day. The five most recent headlines are listed in publication-time order. Press releases from the company itself typically appear within minutes of the wire release; third-party reporting may lag by 30-60 minutes depending on the source.

What PAHC news moves options pricing?

Three categories move single-name IV most aggressively: scheduled earnings releases (priced into pre-event IV, crushed post-event), unscheduled M&A or strategic announcements (rapid IV expansion, slower decay), and regulatory or legal events (drug-trial readouts, antitrust filings, FDA approvals). Routine news flow (analyst commentary, sector rotation) typically does not move IV meaningfully unless it triggers a cluster of rating changes.

How can I track unusual PAHC options activity related to news?

Unusual options activity often precedes news by hours to days; the canonical signals are volume substantially above the trailing average concentrated in a small number of strikes, atypical put/call skew, and aggressive execution (at-the-ask sweeps or block prints). Cross-reference the per-ticker gamma-exposure and volume-history pages with the news flow above to triangulate informed vs uninformed flow.